Search Results 351-360 of 16561 for Acrivastine

  1. A Study to Evaluate the Combination of Binimetinib and Palbociclib in Treating Patients with KRAS and NRAS Mutant Metastatic or Unresectable Colorectal Cancer - Mayo Clinic

    The purose of this study is to determine how well binimetinib and palbociclib work compared to TAS-102 in treating patients with KRAS and NRAS mutation positive ...

  2. Elvitegravir (oral route) - Side effects & dosage - Mayo Clinic

    Elvitegravir is used in combination with ritonavir and another HIV medicine (eg, atazanavir, darunavir, fosamprenavir, lopinavir, tipranavir) to treat infection ...

  3. Radiopharmaceuticals for advanced prostate cancer - Mayo Clinic

    [MUSIC PLAYING]. Dan Childs, M.D., Oncologist: For a long time, we thought advanced prostate cancer was incurable. But now we see some men who have come in ...

  4. Oncology (Medical) - Clinical trials - Mayo Clinic

    Collection of tissue and blood from patients with residual disease after neoadjuvant systemic therapy for breast cancer. We hope to use these samples to ...

  5. Hematology - Clinical trials

    Hematology — Learn about innovative diagnosis and treatment options for blood diseases, including cancers, at Mayo Clinic.

  6. Pulmonary Medicine Clinical Trials - Medical Professionals

    The primary purpose of this study is to assess the feasibility of performing lung and kidney and lung ultrasound elastography among patients with critical ...

  7. Becaplermin (topical route) - Side effects & dosage - Mayo Clinic

    Becaplermin is used with other ulcer care practices (eg, proper wound care) to treat deep skin ulcers (sores), usually in the lower leg, in patients with ...

  8. Neurology - Clinical trials - Mayo Clinic

    The purpose of this study is to evaluate sporadic (s-) and familial (f-) frontotemporal lobar degeneration (FTLD) patients and asymptomatic family members ...

  9. Anthrax vaccine adsorbed, adjuvanted (intramuscular route) - Side effects & uses - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...

  10. A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130) - Mayo Clinic

    This randomized Phase III, multicenter, open-label study is designed to evaluate the safety and efficacy of atezolizumab in combination with carboplatin + nab- ...